We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.

Key Record Dates

ClinicalTrials.gov Identifier: NCT05596409
Brief Title: ELACESTRANT in Women and Men With CDK4/6 Inhibitor-Naive Estrogen Receptor Positive, HER-2 Negative Metastatic Breast Cancer Study (ELCIN)

First Submitted : October 24, 2022
First Submitted that Met QC Criteria : October 24, 2022
First Posted : October 27, 2022

Last Update Submitted that Met QC Criteria : February 13, 2023
Last Update Posted : February 15, 2023